Comparison of Manual and Semi-Automatic [18F]PSMA-1007 PET Based Contouring Techniques for Intraprostatic Tumor Delineation in Patients With Primary Prostate Cancer and Validation With Histopathology as Standard of Reference

PurposeAccurate contouring of intraprostatic gross tumor volume (GTV) is pivotal for successful delivery of focal therapies and for biopsy guidance in patients with primary prostate cancer (PCa). Contouring of GTVs, using 18-Fluor labeled tracer prostate specific membrane antigen positron emission t...

Full description

Bibliographic Details
Main Authors: Simon K. B. Spohn, Maria Kramer, Selina Kiefer, Peter Bronsert, August Sigle, Wolfgang Schultze-Seemann, Cordula A. Jilg, Tanja Sprave, Lara Ceci, Thomas F. Fassbender, Nils H. Nicolay, Juri Ruf, Anca L. Grosu, Constantinos Zamboglou
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.600690/full
id doaj-24f3f41a699c48f2bf7fa91b21ab40c4
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Simon K. B. Spohn
Simon K. B. Spohn
Maria Kramer
Selina Kiefer
Peter Bronsert
August Sigle
Wolfgang Schultze-Seemann
Cordula A. Jilg
Tanja Sprave
Tanja Sprave
Lara Ceci
Thomas F. Fassbender
Nils H. Nicolay
Nils H. Nicolay
Juri Ruf
Anca L. Grosu
Anca L. Grosu
Constantinos Zamboglou
Constantinos Zamboglou
Constantinos Zamboglou
spellingShingle Simon K. B. Spohn
Simon K. B. Spohn
Maria Kramer
Selina Kiefer
Peter Bronsert
August Sigle
Wolfgang Schultze-Seemann
Cordula A. Jilg
Tanja Sprave
Tanja Sprave
Lara Ceci
Thomas F. Fassbender
Nils H. Nicolay
Nils H. Nicolay
Juri Ruf
Anca L. Grosu
Anca L. Grosu
Constantinos Zamboglou
Constantinos Zamboglou
Constantinos Zamboglou
Comparison of Manual and Semi-Automatic [18F]PSMA-1007 PET Based Contouring Techniques for Intraprostatic Tumor Delineation in Patients With Primary Prostate Cancer and Validation With Histopathology as Standard of Reference
Frontiers in Oncology
primary prostate cancer
focal therapy
contouring
PSMA-PET/CT
histopathology
author_facet Simon K. B. Spohn
Simon K. B. Spohn
Maria Kramer
Selina Kiefer
Peter Bronsert
August Sigle
Wolfgang Schultze-Seemann
Cordula A. Jilg
Tanja Sprave
Tanja Sprave
Lara Ceci
Thomas F. Fassbender
Nils H. Nicolay
Nils H. Nicolay
Juri Ruf
Anca L. Grosu
Anca L. Grosu
Constantinos Zamboglou
Constantinos Zamboglou
Constantinos Zamboglou
author_sort Simon K. B. Spohn
title Comparison of Manual and Semi-Automatic [18F]PSMA-1007 PET Based Contouring Techniques for Intraprostatic Tumor Delineation in Patients With Primary Prostate Cancer and Validation With Histopathology as Standard of Reference
title_short Comparison of Manual and Semi-Automatic [18F]PSMA-1007 PET Based Contouring Techniques for Intraprostatic Tumor Delineation in Patients With Primary Prostate Cancer and Validation With Histopathology as Standard of Reference
title_full Comparison of Manual and Semi-Automatic [18F]PSMA-1007 PET Based Contouring Techniques for Intraprostatic Tumor Delineation in Patients With Primary Prostate Cancer and Validation With Histopathology as Standard of Reference
title_fullStr Comparison of Manual and Semi-Automatic [18F]PSMA-1007 PET Based Contouring Techniques for Intraprostatic Tumor Delineation in Patients With Primary Prostate Cancer and Validation With Histopathology as Standard of Reference
title_full_unstemmed Comparison of Manual and Semi-Automatic [18F]PSMA-1007 PET Based Contouring Techniques for Intraprostatic Tumor Delineation in Patients With Primary Prostate Cancer and Validation With Histopathology as Standard of Reference
title_sort comparison of manual and semi-automatic [18f]psma-1007 pet based contouring techniques for intraprostatic tumor delineation in patients with primary prostate cancer and validation with histopathology as standard of reference
publisher Frontiers Media S.A.
series Frontiers in Oncology
issn 2234-943X
publishDate 2020-12-01
description PurposeAccurate contouring of intraprostatic gross tumor volume (GTV) is pivotal for successful delivery of focal therapies and for biopsy guidance in patients with primary prostate cancer (PCa). Contouring of GTVs, using 18-Fluor labeled tracer prostate specific membrane antigen positron emission tomography ([18F]PSMA-1007/PET) has not been examined yet.Patients and MethodsTen Patients with primary PCa who underwent [18F]PSMA-1007 PET followed by radical prostatectomy were prospectively enrolled. Coregistered histopathological gross tumor volume (GTV-Histo) was used as standard of reference. PSMA-PET images were contoured on two ways: (1) manual contouring with PET scaling SUVmin-max: 0–10 was performed by three teams with different levels of experience. Team 1 repeated contouring at a different time point, resulting in n = 4 manual contours. (2) Semi-automatic contouring approaches using SUVmax thresholds of 20–50% were performed. Interobserver agreement was assessed for manual contouring by calculating the Dice Similarity Coefficient (DSC) and for all approaches sensitivity, specificity were calculated by dividing the prostate in each CT slice into four equal quadrants under consideration of histopathology as standard of reference.ResultsManual contouring yielded an excellent interobserver agreement with a median DSC of 0.90 (range 0.87–0.94). Volumes derived from scaling SUVmin-max 0–10 showed no statistically significant difference from GTV-Histo and high sensitivities (median 87%, range 84–90%) and specificities (median 96%, range 96–100%). GTVs using semi-automatic segmentation applying a threshold of 20–40% of SUVmax showed no significant difference in absolute volumes to GTV-Histo, GTV-SUV50% was significantly smaller. Best performing semi-automatic contour (GTV-SUV20%) achieved high sensitivity (median 93%) and specificity (median 96%). There was no statistically significant difference to SUVmin-max 0–10.ConclusionManual contouring with PET scaling SUVmin-max 0–10 and semi-automatic contouring applying a threshold of 20% of SUVmax achieved high sensitivities and very high specificities and are recommended for [18F]PSMA-1007 PET based focal therapy approaches. Providing high specificities, semi-automatic approaches applying thresholds of 30–40% of SUVmax are recommend for biopsy guidance.
topic primary prostate cancer
focal therapy
contouring
PSMA-PET/CT
histopathology
url https://www.frontiersin.org/articles/10.3389/fonc.2020.600690/full
work_keys_str_mv AT simonkbspohn comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference
AT simonkbspohn comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference
AT mariakramer comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference
AT selinakiefer comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference
AT peterbronsert comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference
AT augustsigle comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference
AT wolfgangschultzeseemann comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference
AT cordulaajilg comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference
AT tanjasprave comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference
AT tanjasprave comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference
AT laraceci comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference
AT thomasffassbender comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference
AT nilshnicolay comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference
AT nilshnicolay comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference
AT juriruf comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference
AT ancalgrosu comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference
AT ancalgrosu comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference
AT constantinoszamboglou comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference
AT constantinoszamboglou comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference
AT constantinoszamboglou comparisonofmanualandsemiautomatic18fpsma1007petbasedcontouringtechniquesforintraprostatictumordelineationinpatientswithprimaryprostatecancerandvalidationwithhistopathologyasstandardofreference
_version_ 1724390931653722112
spelling doaj-24f3f41a699c48f2bf7fa91b21ab40c42020-12-08T08:33:48ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2020-12-011010.3389/fonc.2020.600690600690Comparison of Manual and Semi-Automatic [18F]PSMA-1007 PET Based Contouring Techniques for Intraprostatic Tumor Delineation in Patients With Primary Prostate Cancer and Validation With Histopathology as Standard of ReferenceSimon K. B. Spohn0Simon K. B. Spohn1Maria Kramer2Selina Kiefer3Peter Bronsert4August Sigle5Wolfgang Schultze-Seemann6Cordula A. Jilg7Tanja Sprave8Tanja Sprave9Lara Ceci10Thomas F. Fassbender11Nils H. Nicolay12Nils H. Nicolay13Juri Ruf14Anca L. Grosu15Anca L. Grosu16Constantinos Zamboglou17Constantinos Zamboglou18Constantinos Zamboglou19Department of Radiation Oncology, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyGerman Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, GermanyDepartment of Radiation Oncology, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyInstitute for Surgical Pathology, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyInstitute for Surgical Pathology, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyDepartment of Urology, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyDepartment of Urology, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyDepartment of Urology, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyDepartment of Radiation Oncology, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyGerman Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, GermanyDepartment of Radiation Oncology, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyDepartment of Nuclear Medicine, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyDepartment of Radiation Oncology, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyGerman Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, GermanyDepartment of Nuclear Medicine, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyDepartment of Radiation Oncology, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyGerman Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, GermanyDepartment of Radiation Oncology, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, GermanyGerman Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, GermanyBerta-Ottenstein-Programme, Faculty of Medicine, University of Freiburg, Freiburg, GermanyPurposeAccurate contouring of intraprostatic gross tumor volume (GTV) is pivotal for successful delivery of focal therapies and for biopsy guidance in patients with primary prostate cancer (PCa). Contouring of GTVs, using 18-Fluor labeled tracer prostate specific membrane antigen positron emission tomography ([18F]PSMA-1007/PET) has not been examined yet.Patients and MethodsTen Patients with primary PCa who underwent [18F]PSMA-1007 PET followed by radical prostatectomy were prospectively enrolled. Coregistered histopathological gross tumor volume (GTV-Histo) was used as standard of reference. PSMA-PET images were contoured on two ways: (1) manual contouring with PET scaling SUVmin-max: 0–10 was performed by three teams with different levels of experience. Team 1 repeated contouring at a different time point, resulting in n = 4 manual contours. (2) Semi-automatic contouring approaches using SUVmax thresholds of 20–50% were performed. Interobserver agreement was assessed for manual contouring by calculating the Dice Similarity Coefficient (DSC) and for all approaches sensitivity, specificity were calculated by dividing the prostate in each CT slice into four equal quadrants under consideration of histopathology as standard of reference.ResultsManual contouring yielded an excellent interobserver agreement with a median DSC of 0.90 (range 0.87–0.94). Volumes derived from scaling SUVmin-max 0–10 showed no statistically significant difference from GTV-Histo and high sensitivities (median 87%, range 84–90%) and specificities (median 96%, range 96–100%). GTVs using semi-automatic segmentation applying a threshold of 20–40% of SUVmax showed no significant difference in absolute volumes to GTV-Histo, GTV-SUV50% was significantly smaller. Best performing semi-automatic contour (GTV-SUV20%) achieved high sensitivity (median 93%) and specificity (median 96%). There was no statistically significant difference to SUVmin-max 0–10.ConclusionManual contouring with PET scaling SUVmin-max 0–10 and semi-automatic contouring applying a threshold of 20% of SUVmax achieved high sensitivities and very high specificities and are recommended for [18F]PSMA-1007 PET based focal therapy approaches. Providing high specificities, semi-automatic approaches applying thresholds of 30–40% of SUVmax are recommend for biopsy guidance.https://www.frontiersin.org/articles/10.3389/fonc.2020.600690/fullprimary prostate cancerfocal therapycontouringPSMA-PET/CThistopathology